Navigation Links
Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
Date:8/27/2012

EAST BRUNSWICK, N.J., Aug. 27, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that Louis Ferrari, Chief Executive Officer and President of Savient, will present at the Rodman & Renshaw 14th Annual Healthcare Conference on Monday, September 10th at 4:30 pm Eastern Time at the Waldorf=Astoria Hotel in New York City.

A live webcast of the presentation can be accessed through the investor relations section of the Company's website at www.savient.com.  Following the live presentation, a replay of the webcast will be available on the Company's website for 30 days.

ABOUT SAVIENT PHARMACEUTICALS, INC.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

SVNT – GContact: Mary Coleman 

Caitlyn MurphySavient Pharmaceuticals, Inc. 

Burns McClellan information@savient.comcmurphy@burnsmc.com (732) 418-9300

(212) 213-0006


'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
2. Savient Pharmaceuticals Adopts Stockholder Rights Plan
3. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
4. Savient Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call on Wednesday, August 8, 2012
5. Savient Pharmaceuticals Announces CEO Appointment and Reorganization Plan to Drive Long-Term Growth
6. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
9. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
10. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
11. Actinium Pharmaceuticals Strengthens Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... India , January 16, 2017 ... Market Research, titled, "Sterilization Technologies Market by Type and ... the global sterilization technologies market is expected to reach ... growing at a CAGR of 5.8% from 2016 to ... market in 2015, with more than half share, in ...
(Date:1/16/2017)... January 16, 2017 Bill is an internationally ... general management and leadership positions with global medical device companies, including ... track record of launching new products and building successful businesses in ... Africa and North America ... Educated at ...
(Date:1/16/2017)... , Jan. 16, 2017 CBDRx, the ... large amounts of phyto-nutrient rich hemp extract to Veteran,s ... donation of their proprietary hemp extract to Veteran,s groups ... the best hemp company in the world and through ... most nutritious, full spectrum phyto-nutrient rich hemp extract available. ...
Breaking Medicine Technology:
(Date:1/14/2017)... ... January 13, 2017 , ... According to ... magnesium-rich Mediterranean diet may lower the risk of type 2 diabetes, Alzheimer’s, and ... many health and wellness benefits linked to a Mediterranean diet are only some ...
(Date:1/14/2017)... ... ... is a self animating masking transition which allows users to reveal any object or subject ... CEO of Pixel Film Studios. , TransFreeze Volume 3 provides FCPX users ... , To use “Cut-Out First” presets, choose a video clip and hold the ...
(Date:1/13/2017)... Spain (PRWEB) , ... January 13, 2017 , ... The ... Melia Avenida America hotel on March 3-4, 2017. This Congress is expertly designed ... on the management of patients with lung cancer. , Chaired by Dr. Giorgio V. ...
(Date:1/13/2017)... , ... January 13, 2017 , ... KOAMTAC ®, ... will be showcasing the next generation companion scanner and data collector at the National ... KDC270 has been created as an answer to the market’s need for more compact ...
(Date:1/13/2017)... PITTSBURGH, PA (PRWEB) , ... January 13, 2017 , ... An inventor from Pahrump, Nev., ... many others. "My urologist had me wear a Foley catheter and urine bag for a ... difficult and uncomfortable, so I decided that there should be a better way to do ...
Breaking Medicine News(10 mins):